Literature DB >> 21844910

The intestinal microbiota and chronic disorders of the gut.

Andrew W DuPont1, Herbert L DuPont.   

Abstract

Mucosal surfaces of the gut are colonized by large numbers of heterogeneous bacteria that contribute to intestinal health and disease. In genetically susceptible individuals, a 'pathogenic community' may arise, whereby abnormal gut flora contributes to alterations in the mucosa and local immune system leading to gastrointestinal disease. These diseases include enteric infections, such as Clostridium difficile infection, small intestinal bacterial overgrowth, functional gastrointestinal disorders (including IBS), IBD and colorectal cancer. Prebiotics, probiotics and synbiotics (a combination of prebiotics and probiotics) have the capacity to reverse pathologic changes in gut flora and local immunity. Intestinal health and disease need to be thoroughly characterized to understand the interplay between the indigenous microbiota, the immune system and genetic host factors. This Review provides a broad overview of the importance of the intestinal microbiota in chronic disorders of the gut.

Entities:  

Mesh:

Year:  2011        PMID: 21844910     DOI: 10.1038/nrgastro.2011.133

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  125 in total

Review 1.  Infections and cancer: established associations and new hypotheses.

Authors:  Catherine de Martel; Silvia Franceschi
Journal:  Crit Rev Oncol Hematol       Date:  2008-09-20       Impact factor: 6.312

2.  Intestinal permeability in liver cirrhosis: relationship with severe septic complications.

Authors:  B Campillo; P Pernet; P N Bories; J P Richardet; M Devanlay; C Aussel
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 2.566

3.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

4.  Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.

Authors:  Simone Maccaferri; Beatrice Vitali; Annett Klinder; Sofia Kolida; Maurice Ndagijimana; Luca Laghi; Fiorella Calanni; Patrizia Brigidi; Glenn R Gibson; Adele Costabile
Journal:  J Antimicrob Chemother       Date:  2010-09-18       Impact factor: 5.790

5.  Neonatal exposure to fecal antigens reduces intestinal inflammation.

Authors:  Beate C Sydora; Sarah M McFarlane; Jason S G Doyle; Richard N Fedorak
Journal:  Inflamm Bowel Dis       Date:  2010-09-07       Impact factor: 5.325

6.  Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis.

Authors:  Djahida Bouskra; Christophe Brézillon; Marion Bérard; Catherine Werts; Rosa Varona; Ivo Gomperts Boneca; Gérard Eberl
Journal:  Nature       Date:  2008-11-05       Impact factor: 49.962

Review 7.  The expanding universe of inflammatory bowel disease genetics.

Authors:  Jean-Paul Achkar; Richard Duerr
Journal:  Curr Opin Gastroenterol       Date:  2008-07       Impact factor: 3.287

8.  Deletion of TLR5 results in spontaneous colitis in mice.

Authors:  Matam Vijay-Kumar; Catherine J Sanders; Rebekah T Taylor; Amrita Kumar; Jesse D Aitken; Shanthi V Sitaraman; Andrew S Neish; Satoshi Uematsu; Shizuo Akira; Ifor R Williams; Andrew T Gewirtz
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia.

Authors:  Tilman M Bauer; Henning Schwacha; Bernhard Steinbrückner; Folke E Brinkmann; Anette K Ditzen; John J Aponte; Klaus Pelz; Dieter Berger; Manfred Kist; Hubert E Blum
Journal:  Am J Gastroenterol       Date:  2002-09       Impact factor: 10.864

10.  Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.

Authors:  Ben Willing; Jonas Halfvarson; Johan Dicksved; Magnus Rosenquist; Gunnar Järnerot; Lars Engstrand; Curt Tysk; Janet K Jansson
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

View more
  114 in total

Review 1.  Plasticity of the brush border - the yin and yang of intestinal homeostasis.

Authors:  Delphine Delacour; Julie Salomon; Sylvie Robine; Daniel Louvard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-03       Impact factor: 46.802

Review 2.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

Review 3.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 4.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

5.  Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.

Authors:  James H Tabibian; Steven P O'Hara; Christy E Trussoni; Pamela S Tietz; Patrick L Splinter; Taofic Mounajjed; Lee R Hagey; Nicholas F LaRusso
Journal:  Hepatology       Date:  2015-08-10       Impact factor: 17.425

6.  The tuning of the gut nervous system by commensal microbiota.

Authors:  Nobuhiko Kamada; John Y Kao
Journal:  Gastroenterology       Date:  2013-12       Impact factor: 22.682

Review 7.  The Burden of Enteropathy and "Subclinical" Infections.

Authors:  Elizabeth T Rogawski; Richard L Guerrant
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

8.  Can Peptides and Gut Microbiota Be Involved in the Etiopathology of Obesity?

Authors:  Suleyman Aydin
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

9.  Effect of dietary monosaccharides on Pseudomonas aeruginosa virulence.

Authors:  Ryan K Nelson; Valeriy Poroyko; Michael J Morowitz; Don Liu; John C Alverdy
Journal:  Surg Infect (Larchmt)       Date:  2013-03-01       Impact factor: 2.150

10.  Aflatoxin B1 Induced Compositional Changes in Gut Microbial Communities of Male F344 Rats.

Authors:  Jincheng Wang; Lili Tang; Travis C Glenn; Jia-Sheng Wang
Journal:  Toxicol Sci       Date:  2015-11-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.